£119.49

This is the most expensive it has ever been. Walk away.

£119 today · previous high £119 · all-time low £117

Elsevier Interventional Management of Migraines and Headache Disorders Book

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 53 days · 53 data points (no recent data)

Historical
Generating forecast…
£119.49 £116.70 £117.31 £117.92 £118.52 £119.13 £119.74 11 August 2026 24 August 2026 06 September 2026 19 September 2026 02 October 2026
View at Amazon ↗

Price data last checked 38 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 53 days • 2 price levels

Days at Price
Current Price
49 days 4 days · current 0 12 25 37 49 £117 £119 Days at Price

Price Analysis

Most common price: £117 (49 days, 92.5%)

Price range: £117 - £119

Price levels: 2 different prices over 53 days

Description

Interventional Management of Migraines and Other Headache Disorders is a comprehensive clinical resource published by Academic Press that covers interventional treatment options for migraine headaches and associated headache disorders. This medical textbook examines mechanisms of action, indications, contraindications, and treatment efficacy whilst providing fundamental principles of interventional procedures including patient selection, preparation, and monitoring protocols. Healthcare professionals and clinicians will find practical guidance on selecting, administering, and evaluating interventional treatments, making this an essential reference for neurologists and medical practitioners specialising in headache management and pain relief strategies.

Key Features

Academic Press publication covering interventional approaches to migraine and headache disorder treatment options.

Detailed mechanisms of action and efficacy data for clinical decision-making by healthcare professionals.

Comprehensive patient selection criteria, preparation protocols, and monitoring guidelines for interventional procedures.

Practical clinical instructions for administering and evaluating interventional migraine treatments in healthcare settings.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Interventional Management of Headache Pain
99% match

Interventional Management of Headache Pain

Elsevier

£147.99 19 Sep 2026
Comorbid Conditions in the Treatment of Headache
98% match

Comorbid Conditions in the Treatment of Headache

CRC Press

£75.11 11 Sep 2026
Migraine and Headache Disorders: Global Perspective - SDG3
98% match

Migraine and Headache Disorders: Global Perspective - SDG3

Springer

£95.74 25 Sep 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
98% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026
Migraine, Words and Fiction
98% match

Migraine, Words and Fiction

Cambridge Scholars Publishing

£67.99 23 Sep 2026
Clinical Scales for Headache Disorders
98% match

Clinical Scales for Headache Disorders

Springer

£95.74 19 Sep 2026
Neuroimaging of Headache Disorders
98% match

Neuroimaging of Headache Disorders

Springer

£101.05 18 Sep 2026
Springer - Surgical Treatment of Chronic Headaches and Migraines
98% match

Springer - Surgical Treatment of Chronic Headaches and Migraines

Springer

£65.64 28 Oct 2026
Migraine
98% match

Migraine

IntechOpen

£118.98 12 Sep 2026
The Biochemistry of Migraine
98% match

The Biochemistry of Migraine

Springer

£158.11 19 Sep 2026
Headache: Evaluation and Management
97% match

Headache: Evaluation and Management

Foster Academics

£71.12 18 Sep 2026
Monoclonal Antibodies in Headache: From Bench to Patient
97% match

Monoclonal Antibodies in Headache: From Bench to Patient

Springer

£71.84 22 Sep 2026
Migraine Biology, Diagnosis, and Co-Morbidities (Volume 198) (Handbook of Clinical Neurology, Volume 198)
97% match

Migraine Biology, Diagnosis, and Co-Morbidities (Volume 198) (Handbook of Clinical Neurology, Volume 198)

Elsevier

£182.75 04 Nov 2026
Headache and Comorbidities in Childhood and Adolescence
97% match

Headache and Comorbidities in Childhood and Adolescence

Springer

£80.65 17 Sep 2026
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
97% match

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

OmniScriptum

£70.00 30 Sep 2026
Anti-Migraine Drugs in India Outlook 2023-2028 Study
97% match

Anti-Migraine Drugs in India Outlook 2023-2028 Study

£515.00 24 Aug 2026
US Anti-Migraine Drug Market Outlook 2023-2028 Study
97% match

US Anti-Migraine Drug Market Outlook 2023-2028 Study

£520.00 07 Nov 2026
Headache Disorders in Pandemic Conditions
97% match

Headache Disorders in Pandemic Conditions

Springer

£95.74 19 Sep 2026
Headache Disorders in Pandemic Conditions
97% match

Headache Disorders in Pandemic Conditions

Springer

£73.11 18 Sep 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in India
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in India

£595.00 03 Nov 2026
US Anti-Migraine Drug Market Outlook 2016-2021 Study
97% match

US Anti-Migraine Drug Market Outlook 2016-2021 Study

£595.00 06 Nov 2026
Anti-Migraine Drug Outlook in Greater China 2016-2021
97% match

Anti-Migraine Drug Outlook in Greater China 2016-2021

£595.00 25 Aug 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in China
97% match

The 2023-2028 Outlook for Anti-Migraine Drugs in China

£495.00 04 Nov 2026
Anti-Migraine Drug Outlook Latin America 2016-2021 Study
97% match

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

£425.00 07 Nov 2026